Search

Eric Olson

Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1693, 1673, 1623
Total Applications
1758
Issued Applications
971
Pending Applications
175
Abandoned Applications
632

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19290410 [patent_doc_number] => 12029749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-09 [patent_title] => Methods of treatment and maintenance therapy for bladder cancer using gemcitabine [patent_app_type] => utility [patent_app_number] => 17/010648 [patent_app_country] => US [patent_app_date] => 2020-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26169 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/010648
Methods of treatment and maintenance therapy for bladder cancer using gemcitabine Sep 1, 2020 Issued
Array ( [id] => 18244492 [patent_doc_number] => 20230076803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => COMPOUND AND DRUG CONJUGATE, AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/639063 [patent_app_country] => US [patent_app_date] => 2020-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639063 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/639063
COMPOUND AND DRUG CONJUGATE, AND PREPARATION METHOD AND USE THEREOF Aug 27, 2020 Pending
Array ( [id] => 18051605 [patent_doc_number] => 11524976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-13 [patent_title] => Oligonucleotide synthesizer [patent_app_type] => utility [patent_app_number] => 17/005854 [patent_app_country] => US [patent_app_date] => 2020-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7274 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005854 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/005854
Oligonucleotide synthesizer Aug 27, 2020 Issued
Array ( [id] => 17850588 [patent_doc_number] => 20220280629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => ANTIMICROBIAL VACCINE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/638732 [patent_app_country] => US [patent_app_date] => 2020-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16934 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638732 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/638732
ANTIMICROBIAL VACCINE COMPOSITIONS Aug 26, 2020 Pending
Array ( [id] => 16898105 [patent_doc_number] => 20210177021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => METHOD OF PRODUCTION [patent_app_type] => utility [patent_app_number] => 16/999483 [patent_app_country] => US [patent_app_date] => 2020-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999483 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/999483
METHOD OF PRODUCTION Aug 20, 2020 Abandoned
Array ( [id] => 16483840 [patent_doc_number] => 20200377441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE [patent_app_type] => utility [patent_app_number] => 16/997255 [patent_app_country] => US [patent_app_date] => 2020-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49313 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997255 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/997255
METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE Aug 18, 2020 Abandoned
Array ( [id] => 17913224 [patent_doc_number] => 20220315619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => (HETERO)ARYL-METHYL-THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/633895 [patent_app_country] => US [patent_app_date] => 2020-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28510 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633895 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/633895
(Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives Aug 6, 2020 Issued
Array ( [id] => 20213566 [patent_doc_number] => 12410208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => (2-acetamidyl)thio-beta-D-galactopyranoside derivatives [patent_app_type] => utility [patent_app_number] => 17/633941 [patent_app_country] => US [patent_app_date] => 2020-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22999 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633941 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/633941
(2-acetamidyl)thio-beta-D-galactopyranoside derivatives Aug 5, 2020 Issued
Array ( [id] => 17697071 [patent_doc_number] => 11370781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-28 [patent_title] => Combination therapy for treating cancer [patent_app_type] => utility [patent_app_number] => 16/985404 [patent_app_country] => US [patent_app_date] => 2020-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 38794 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16985404 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/985404
Combination therapy for treating cancer Aug 4, 2020 Issued
Array ( [id] => 16569091 [patent_doc_number] => 20210008097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => Compositions Comprising Galactose-Pronged Polysaccharides [patent_app_type] => utility [patent_app_number] => 16/983760 [patent_app_country] => US [patent_app_date] => 2020-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8465 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983760 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/983760
Compositions Comprising Galactose-Pronged Polysaccharides Aug 2, 2020 Abandoned
Array ( [id] => 17620149 [patent_doc_number] => 11339187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-24 [patent_title] => Process for the preparation of GalNAc oligonucleotide conjugates [patent_app_type] => utility [patent_app_number] => 16/939849 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5916 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939849 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/939849
Process for the preparation of GalNAc oligonucleotide conjugates Jul 26, 2020 Issued
Array ( [id] => 16437071 [patent_doc_number] => 20200354397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => PHOSPHORAMIDITE SYNTHONES FOR THE SYNTHESIS OF SELF-NEUTRALIZING OLIGONUCLEOTIDE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/940039 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940039 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/940039
Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds Jul 26, 2020 Issued
Array ( [id] => 16619976 [patent_doc_number] => 20210038629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => COMPOUNDS AND METHODS FOR MODULATING GFAP [patent_app_type] => utility [patent_app_number] => 16/938826 [patent_app_country] => US [patent_app_date] => 2020-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56287 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938826 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/938826
Compounds and methods for modulating GFAP Jul 23, 2020 Issued
Array ( [id] => 16569083 [patent_doc_number] => 20210008089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER [patent_app_type] => utility [patent_app_number] => 16/929690 [patent_app_country] => US [patent_app_date] => 2020-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929690 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/929690
COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER Jul 14, 2020 Abandoned
Array ( [id] => 16791669 [patent_doc_number] => 20210121486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/921562 [patent_app_country] => US [patent_app_date] => 2020-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50325 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921562 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/921562
ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE Jul 5, 2020 Abandoned
Array ( [id] => 17774917 [patent_doc_number] => 20220241266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE [patent_app_type] => utility [patent_app_number] => 17/597343 [patent_app_country] => US [patent_app_date] => 2020-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597343 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/597343
COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE Jul 2, 2020 Abandoned
Array ( [id] => 17774917 [patent_doc_number] => 20220241266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE [patent_app_type] => utility [patent_app_number] => 17/597343 [patent_app_country] => US [patent_app_date] => 2020-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597343 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/597343
COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE Jul 2, 2020 Abandoned
Array ( [id] => 16359347 [patent_doc_number] => 20200316098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => TERNARY MIXTURES OF 6'-SL, LNnT and LST c [patent_app_type] => utility [patent_app_number] => 16/913590 [patent_app_country] => US [patent_app_date] => 2020-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9354 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913590 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/913590
TERNARY MIXTURES OF 6'-SL, LNnT and LST c Jun 25, 2020 Abandoned
Array ( [id] => 16523727 [patent_doc_number] => 20200397807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES [patent_app_type] => utility [patent_app_number] => 16/904270 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904270 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/904270
NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES Jun 16, 2020 Abandoned
Array ( [id] => 17761483 [patent_doc_number] => 20220235095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => SAPONIN PURIFICATION [patent_app_type] => utility [patent_app_number] => 17/615254 [patent_app_country] => US [patent_app_date] => 2020-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21036 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615254 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/615254
SAPONIN PURIFICATION Jun 2, 2020 Pending
Menu